Literature DB >> 11069621

Carboxyfullerenes protect human keratinocytes from ultraviolet-B-induced apoptosis.

C Fumelli1, A Marconi, S Salvioli, E Straface, W Malorni, A M Offidani, R Pellicciari, G Schettini, A Giannetti, D Monti, C Franceschi, C Pincelli.   

Abstract

Carboxyfullerene, a water-soluble carboxylic acid derivative of a fullerene, which acts as a free-radical scavenger, was investigated as a protective agent against ultraviolet-light-induced damage in human keratinocytes. First, we demonstrate that carboxyfullerene is not cytotoxic for these cells. In addition, this compound significantly reduces the ultraviolet-B-induced inhibition of keratinocyte proliferation and protects keratinocytes from apoptosis caused by ultraviolet B irradiation in a time- and dose-dependent fashion. Furthermore, the percentage of cells with depolarized mitochondria is significantly lower in ultraviolet-B-irradiated keratinocytes pretreated with carboxyfullerene than in cells provided with diluent alone. Carboxyfullerene also protects human keratinocytes from apoptosis induced by exposure to deoxy-D-ribose, a sugar that causes cell death through a pathway involving oxidative stress. On the other hand, ultraviolet B downregulates bcl-2 levels in human keratinocytes, and carboxyfullerene fails to prevent this effect. These results suggest that carboxy- fullerene protects human keratinocytes from ultraviolet B damage possibly via a mechanism interfering with the generation of reactive oxygen species from depolarized mitochondria without the involvement of bcl-2.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069621     DOI: 10.1046/j.1523-1747.2000.00140.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Synthesis and properties of novel water-soluble fullerene-glycine derivatives as new materials for cancer therapy.

Authors:  Guichang Jiang; Fen Yin; Jihua Duan; Guangtao Li
Journal:  J Mater Sci Mater Med       Date:  2015-01-13       Impact factor: 3.896

2.  Uptake and distribution of fullerenes in human mast cells.

Authors:  Anthony Dellinger; Zhiguo Zhou; Sarah K Norton; Robert Lenk; Daniel Conrad; Christopher L Kepley
Journal:  Nanomedicine       Date:  2010-02-04       Impact factor: 5.307

3.  [Gd@C(82)(OH)(22)](n) nanoparticles induce dendritic cell maturation and activate Th1 immune responses.

Authors:  De Yang; Yuliang Zhao; Hua Guo; Yana Li; Poonam Tewary; Gengmei Xing; Wei Hou; Joost J Oppenheim; Ning Zhang
Journal:  ACS Nano       Date:  2010-02-23       Impact factor: 15.881

4.  Modulation of tumor necrosis factor-mediated cell death by fullerenes.

Authors:  Ljubica Harhaji; Aleksandra Isakovic; Ljubica Vucicevic; Kristina Janjetovic; Maja Misirkic; Zoran Markovic; Biljana Todorovic-Markovic; Nadezda Nikolic; Sanja Vranjes-Djuric; Zoran Nikolic; Vladimir Trajkovic
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

5.  Fullerene nanomaterials inhibit phorbol myristate acetate-induced inflammation.

Authors:  Anthony Dellinger; Zhiguo Zhou; Robert Lenk; Darren MacFarland; Christopher L Kepley
Journal:  Exp Dermatol       Date:  2009-12       Impact factor: 3.960

6.  Inhibition of inflammatory arthritis using fullerene nanomaterials.

Authors:  Anthony L Dellinger; Pierre Cunin; David Lee; Andrew L Kung; D Bradford Brooks; Zhiguo Zhou; Peter A Nigrovic; Christopher L Kepley
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

7.  Differential Cytotoxicity Induced by Transition Metal Oxide Nanoparticles is a Function of Cell Killing and Suppression of Cell Proliferation.

Authors:  Larry M Tolliver; Natalie J Holl; Fang Yao Stephen Hou; Han-Jung Lee; Melissa H Cambre; Yue-Wern Huang
Journal:  Int J Mol Sci       Date:  2020-03-03       Impact factor: 5.923

8.  Comparative computational study of interaction of C60-fullerene and tris-malonyl-C60-fullerene isomers with lipid bilayer: relation to their antioxidant effect.

Authors:  Marine E Bozdaganyan; Philipp S Orekhov; Alexey K Shaytan; Konstantin V Shaitan
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.